Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Adams

Showing results (731-740 of 830) with videos related to

Pageof 83
Sort By:
Journal of the American College of Cardiology|December 19, 2003
Gender differences in advanced heart failure: insights from the BEST studyJalal K Ghali, Heidi J Krause-Steinrauf, Kirkwood F Adams, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
Cancer Cytopathology|October 28, 2014
Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou testsChristopher L Owens, Diana S M Buist, Daniel Peterson, et al.
European Journal of Heart Failure|February 28, 2014
A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profileKirkwood F Adams, Jalal K Ghali, J Herbert Patterson, et al.
Journal of Cardiac Failure|December 6, 2013
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTIONMona Fiuzat, Phillip J Schulte, Michael Felker, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profilesShaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.
AJR. American Journal of Roentgenology|April 1, 1997
Expediting the turnaround of radiology reports in a teaching hospital settingS E Seltzer, P Kelly, D F Adams, et al.
Annals of Internal Medicine|September 1, 1990
Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery diseaseD S Sheps, M C Herbst, A L Hinderliter, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Pageof 83

Showing results (731-740 of 830) with videos related to

Sort By:
Pageof 83
Journal of the American College of Cardiology|December 19, 2003
Gender differences in advanced heart failure: insights from the BEST studyJalal K Ghali, Heidi J Krause-Steinrauf, Kirkwood F Adams, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
Cancer Cytopathology|October 28, 2014
Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou testsChristopher L Owens, Diana S M Buist, Daniel Peterson, et al.
European Journal of Heart Failure|February 28, 2014
A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profileKirkwood F Adams, Jalal K Ghali, J Herbert Patterson, et al.
Journal of Cardiac Failure|December 6, 2013
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTIONMona Fiuzat, Phillip J Schulte, Michael Felker, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profilesShaveta Mehta, Nicholas P Hughes, Francesca M Buffa, et al.
AJR. American Journal of Roentgenology|April 1, 1997
Expediting the turnaround of radiology reports in a teaching hospital settingS E Seltzer, P Kelly, D F Adams, et al.
Annals of Internal Medicine|September 1, 1990
Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery diseaseD S Sheps, M C Herbst, A L Hinderliter, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Pageof 83